Science Explorer Back to mapMap
Discussion
Researcher · Eli Lilly (United States) · United States

Kyle W. Sloop

Kyle W. Sloop publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery, on topics such as Diabetes Treatment and Management, Pancreatic function and diabetes and Receptor Mechanisms and Signaling.

ORCID 0000-0001-6748-9929 OpenAlex
World rank
#107,002
of 7,710,434 ranked researchers
Rank in United States
#40,872
of 1,627,098
Works
142
Citations
7.9k
Citations per work
55.5
h-index
49
i10-index 94Top 3.4% in Endocrinology, Diabetes and Metabolism
Kyle W. Sloop

What does Kyle W. Sloop research?

Kyle W. Sloop's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (29%), Neuroscience (7%).

Health Sciences: 61 works · 43.3% of their workMedicine: 61 works · 43.3% of their workEndocrinology, Diabetes and Metabolism: 36 works · 25.5% of their workSurgery: 20 works · 13.8% of their workPhysiology: 6 works · 4.0% of their workLife Sciences: 50 works · 35.2% of their workBiochemistry, Genetics and Molecular Biology: 41 works · 28.6% of their workMolecular Biology: 32 works · 22.5% of their workGenetics: 9 works · 6.1% of their workNeuroscience: 9 works · 6.6% of their workCellular and Molecular Neuroscience: 9 works · 6.6% of their workEverything else: 31 works · 21.5% of their workTHEIR WORKKyle W. Sloop142works
Life Sciences35%Health Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6143.3%
    1. Biochemistry, Genetics and Molecular Biology4128.6%
    2. Neuroscience96.6%
  3. Everything else3121.5%
  1. 1Endocrinology, Diabetes and Metabolism26% of their works
  2. 2Molecular Biology22% of their works
  3. 3Surgery14% of their works
  4. 4Cellular and Molecular Neuroscience7% of their works
  5. 5Genetics6% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Kyle W. Sloop's research?

The keywords of their largest research topics: Cardiovascular Outcomes, Type 2 Diabetes, Pancreatic Islets, ß-Cell Dysfunction, Crystal Structure, G-Protein-Coupled Receptors, Neuropeptides and Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Cardiovascular Outcomes741 topic
  2. Type 2 Diabetes741 topic
  3. Pancreatic Islets491 topic
  4. ß-Cell Dysfunction491 topic
  5. Crystal Structure331 topic
  6. G-Protein-Coupled Receptors331 topic
  7. Neuropeptides251 topic
  8. Receptors251 topic
  9. Ghrelin141 topic
  10. Leptin141 topic
  11. AMP-Activated Protein Kinase101 topic
  12. Genetics101 topic
  13. IGF-1101 topic
  14. Insulin-like Growth Factors101 topic
  15. Metformin101 topic
  16. Type 1 Diabetes101 topic

Where does Kyle W. Sloop work?

Kyle W. Sloop's main affiliation in the publication record is Eli Lilly (United States), United States.

How many publications and citations does Kyle W. Sloop have?

OpenAlex counts 142 works and 7,884 citations for Kyle W. Sloop, an h-index of 49, ranking #107,002 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kyle W. Sloop. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.